Moderna on March 23 said it plans to submit a request to the FDA “in the coming weeks” for authorization of a low-dose COVID-19 vaccine for children 6 months to under 6 years.
Read the full post on Becker's Hospital Review - Healthcare News
Read the full post on Becker's Hospital Review - Healthcare News